<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>METHIMAZOLE- methimazoleÂ tabletÂ </strong><br>Bryant Ranch Prepack<br></p></div>
<h1>
METHIMAZOLE</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_4fac1b55-e32d-4fd9-9570-b2f69188de1d"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Methimazole (1-methylimidazole-2-thiol) is a white, crystalline substance that is freely soluble in water. It differs chemically from the drugs of the thiouracil series primarily because it has a 5- instead of a 6-membered ring.</p>
<p>Each tablet contains 5 or 10 mg (43.8 or 87.6 Î¼mol) methimazole, an orally administered antithyroid drug. Each tablet also contains lactose monohydrate, magnesium stearate, corn starch, and talc.</p>
<p>The molecular weight is 114.17, and the molecular formula is C<span class="Sub">4</span>H<span class="Sub">6</span>N<span class="Sub">2</span>S. The structural formula is as follows:</p>
<div class="Figure"><img alt="Methimazole Structural Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9e6b80b8-6780-da50-f18f-30e6fe7b01b9&amp;name=2ada5144-b4d9-4aee-bcf6-809d5b773c8b-01.jpg"></div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_bc69f498-37c9-42b7-aee2-b2d1b6660eb8"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Methimazole inhibits the synthesis of thyroid hormones and thus is effective in the treatment of <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>. The drug does not inactivate existing thyroxine and triiodothyronine that are stored in the thyroid or circulating in the blood nor does it interfere with the effectiveness of thyroid hormones given by mouth or by injection.</p>
<p>The actions and use of methimazole are similar to those of propylthiouracil. On a weight basis, the drug is at least 10 times as potent as propylthiouracil, but methimazole may be less consistent in action.</p>
<p>Methimazole is readily absorbed from the gastrointestinal tract. It is metabolized rapidly and requires frequent administration. Methimazole is excreted in the urine.</p>
<p>In laboratory animals, various regimens that continuously suppress thyroid function and thereby increase TSH secretion result in thyroid tissue <span class="product-label-link" type="condition" conceptid="4210465" conceptname="Hypertrophy">hypertrophy</span>. Under such conditions, the appearance of thyroid and pituitary neoplasms has also been reported. Regimens that have been studied in this regard include antithyroid agents as well as dietary iodine deficiency, subtotal thyroidectomy, implantation of autonomous thyrotropic hormone-secreting pituitary tumors, and administration of chemical goitrogens.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_02f3ebe5-0cd2-46b5-b3ce-2863da7d4555"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Methimazole is indicated in the medical treatment of <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>. Long-term therapy may lead to remission of the disease. Methimazole may be used to ameliorate <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span> in preparation for subtotal thyroidectomy or radioactive iodine therapy. Methimazole is also used when thyroidectomy is contraindicated or not advisable.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_f8ac79ac-3e2f-44ad-b7c6-ec4a12aac3aa"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Methimazole is contraindicated in the presence of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to the drug and in nursing mothers because the drug is excreted in milk.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_6e44a038-8c7b-44ee-bdaa-fb84d59dc2b8"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">Agranulocytosis</span> is potentially a serious side effect. Patients should be instructed to report to their physicians any symptoms of <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, such as <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> or <span class="product-label-link" type="condition" conceptid="26711" conceptname="Chronic pharyngitis">sore throat</span>. <span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">Leukopenia</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, and <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">aplastic anemia</span> (<span class="product-label-link" type="condition" conceptid="432881" conceptname="Pancytopenia">pancytopenia</span>) may also occur. The drug should be discontinued in the presence of <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">aplastic anemia</span> (<span class="product-label-link" type="condition" conceptid="432881" conceptname="Pancytopenia">pancytopenia</span>), <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, or <span class="product-label-link" type="condition" conceptid="4270887" conceptname="Erythroderma">exfoliative dermatitis</span>. The patientâ€™s bone marrow function should be monitored.</p>
<p>Due to the similar hepatic toxicity profiles of methimazole and propylthiouracil, attention is drawn to the severe hepatic reactions which have occurred with both drugs. There have been rare reports of fulminant <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, <span class="product-label-link" type="condition" conceptid="4337543" conceptname="Hepatic necrosis">hepatic necrosis</span>, <span class="product-label-link" type="condition" conceptid="372887" conceptname="Disorder of brain">encephalopathy</span>, and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>. Symptoms suggestive of hepatic dysfunction (<span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">right upper quadrant pain</span>, etc.) should prompt evaluation of liver function. Drug treatment should be discontinued promptly in the event of clinically significant evidence of liver abnormality including hepatic transaminase values exceeding 3 times the upper limit of normal.</p>
<p>Methimazole can cause fetal harm when administered to a pregnant woman. Methimazole readily crosses the placental membranes and can induce <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">goiter</span> and even <span class="product-label-link" type="condition" conceptid="133728" conceptname="Congenital hypothyroidism">cretinism</span> in the developing fetus. In addition, rare instances of congenital defects: <span class="product-label-link" type="condition" conceptid="4166825" conceptname="Aplasia">aplasia</span> cutis, as manifested by scalp defects; <span class="product-label-link" type="condition" conceptid="4095108" conceptname="Congenital atresia of esophagus">esophageal atresia</span> with <span class="product-label-link" type="condition" conceptid="25582" conceptname="Tracheoesophageal fistula">tracheoesophageal fistula</span>; and <span class="product-label-link" type="condition" conceptid="256810" conceptname="Choanal atresia">choanal atresia</span> with absent/hypoplastic nipples, have occurred in infants born to mothers who received methimazole during pregnancy. If methimazole is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be warned of the potential hazard to the fetus.</p>
<p>Since the above congenital defects have been reported in offspring of patients treated with methimazole, it may be appropriate to use other agents in pregnant women requiring treatment for <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>.</p>
<p>Postpartum patients receiving methimazole should not nurse their babies.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_ca82abe1-cdf8-43e1-9763-66549b11629d"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_b9444e9e-cd52-4054-af28-69592293cc2d"></a><a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First">Patients who receive methimazole should be under close surveillance and should be cautioned to report immediately any evidence of illness, particularly <span class="product-label-link" type="condition" conceptid="26711" conceptname="Chronic pharyngitis">sore throat</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin eruptions</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, or <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">general malaise</span>. In such cases, white-blood-cell and differential counts should be made to determine whether <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span> has developed. Particular care should be exercised with patients who are receiving additional drugs known to cause <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="i4i_lab_tests_id_8fa5807d-b0c5-4ea2-b313-f6f64df08e3a"></a><a name="section-6.2"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">Because methimazole may cause <span class="product-label-link" type="condition" conceptid="4253058" conceptname="Factor II deficiency">hypoprothrombinemia</span> and <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span>, <span class="product-label-link" type="condition" conceptid="4173906" conceptname="Clotting factor II assay">prothrombin</span> time should be monitored during therapy with the drug, especially before surgical procedures (see <span class="Bold"><a href="#i4i_precautions_general_id_b9444e9e-cd52-4054-af28-69592293cc2d">General</a></span> under <span class="Bold">PRECAUTIONS</span>).</p>
<p>Periodic monitoring of thyroid function is warranted, and the finding of an elevated TSH warrants a decrease in the dosage of methimazole.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="i4i_interactions_id_de3689f2-c2f4-4810-95e9-68573c7be878"></a><a name="section-6.3"></a><p></p>
<h2>Drug Interactions</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_0f16ed02-55f3-4021-842a-17031ac8af56"></a><a name="section-6.3.1"></a><p></p>
<h3>Anticoagulants (oral)</h3>
<p class="First">The activity of oral anticoagulants may be potentiated by anti-vitamin-K activity attributed to methimazole.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_2fff6f56-edb1-4730-a676-fc7dd9f34ffb"></a><a name="section-6.3.2"></a><p></p>
<h3>ÃŸ-adrenergic blocking agents</h3>
<p class="First"><span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">Hyperthyroidism</span> may cause an increased clearance of beta blockers with a high extraction ratio. A dose reduction of beta-adrenergic blockers may be needed when a hyperthyroid patient becomes euthyroid.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_a8073b64-4ae9-4f0a-bda6-c16f14a6a302"></a><a name="section-6.3.3"></a><p></p>
<h3>Digitalis glycosides</h3>
<p class="First">Serum digitalis levels may be increased when hyperthyroid patients on a stable digitalis glycoside regimen become euthyroid; a reduced dosage of digitalis glycosides may be required.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_8216ae56-61f0-4f96-beac-55a769f51503"></a><a name="section-6.3.4"></a><p></p>
<h3>Theophylline</h3>
<p class="First">Theophylline clearance may decrease when hyperthyroid patients on a stable theophylline regimen become euthyroid; a reduced dose of theophylline may be needed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="i4i_carcinogenesis_mutagenesis_fertility_id_58c0a628-b20c-4eb8-942a-5b053ae82097"></a><a name="section-6.4"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">In a 2 year study, rats were given methimazole at doses of 0.5, 3, and 18 mg/kg/day. These doses were 0.3, 2 and 12 times the 15 mg/day maximum human maintenance dose (when calculated on the basis of surface area). <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">Thyroid hyperplasia</span>, <span class="product-label-link" type="condition" conceptid="4106411" conceptname="Adenofibroma">adenoma</span>, and carcinoma developed in rats at the two higher doses. The clinical significance of these findings is unclear.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_6325a4e4-b5e7-4e1a-9cbf-44d1380ce267"></a><a name="section-6.5"></a><p></p>
<h2>Pregnancy Category D</h2>
<p class="First">(See <span class="Bold"><a href="#i4i_warnings_id_6e44a038-8c7b-44ee-bdaa-fb84d59dc2b8">WARNINGS</a></span>)</p>
<p>Methimazole used judiciously is an effective drug in <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span> complicated by pregnancy. In many pregnant women, the thyroid dysfunction diminishes as the pregnancy proceeds; consequently, a reduction in dosage may be possible. In some instances, use of methimazole can be discontinued 2 or 3 weeks before delivery.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_e093b0fc-ede7-46ef-a513-673619d4562a"></a><a name="section-6.6"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">The drug appears in human breast milk and its use is contraindicated in nursing mothers (see <span class="Bold"><a href="#i4i_warnings_id_6e44a038-8c7b-44ee-bdaa-fb84d59dc2b8">WARNINGS</a></span>).</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_fc30c6a8-752a-4b4f-ae1a-0fc7aa432a42"></a><a name="section-6.7"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">(See <span class="Bold"><a href="#i4i_dosage_admin_id_6eb1d33f-d38d-497f-bc40-dea6efaa1536">DOSAGE AND ADMINISTRATION</a></span>).</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_a8d10cd4-867a-4b6a-8512-cc852270e2cc"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Major adverse reactions (which occur with much less frequency than the minor adverse reactions) include inhibition of myelopoiesis (<span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="4218497" conceptname="Granulocytopenic disorder">granulocytopenia</span>, and <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>), <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">aplastic anemia</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">drug fever</span>, a lupus like syndrome, <span class="product-label-link" type="condition" conceptid="4252384" conceptname="Insulin autoimmune syndrome">insulin autoimmune syndrome</span> (which can result in <span class="product-label-link" type="condition" conceptid="380688" conceptname="Hypoglycemic coma">hypoglycemic coma</span>), <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span> (<span class="product-label-link" type="condition" conceptid="137977" conceptname="Jaundice">jaundice</span> may persist for several weeks after discontinuation of the drug), periarteritis, and <span class="product-label-link" type="condition" conceptid="4253058" conceptname="Factor II deficiency">hypoprothrombinemia</span>. <span class="product-label-link" type="condition" conceptid="193253" conceptname="Nephritis">Nephritis</span> occurs very rarely.</p>
<p>Minor adverse reactions include <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">epigastric distress</span>, <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">arthralgia</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesia</span>, <span class="product-label-link" type="condition" conceptid="4289517" conceptname="Loss of taste">loss of taste</span>, abnormal loss of hair, <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">myalgia</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="444252" conceptname="Neuritis">neuritis</span>, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">vertigo</span>, <span class="product-label-link" type="condition" conceptid="4083855" conceptname="Abnormal pigment">skin pigmentation</span>, <span class="product-label-link" type="condition" conceptid="137977" conceptname="Jaundice">jaundice</span>, sialadenopathy, and <span class="product-label-link" type="condition" conceptid="315085" conceptname="Lymphadenopathy">lymphadenopathy</span>.</p>
<p>It should be noted that about 10% of patients with untreated <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span> have <span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">leukopenia</span> (white-blood-cell count of less than 4,000/mm<span class="Sup">3</span>), often with relative granulopenia.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="i4i_overdosage_id_4c2f88db-3f44-4f37-9ffe-293aef384c8e"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_714681b6-cd02-49d8-9b66-9b7860bd37eb"></a><a name="section-8.1"></a><p></p>
<h2>Signs and Symptoms</h2>
<p class="First">Symptoms may include <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">epigastric distress</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">joint pain</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, and <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>. <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">Aplastic anemia</span> (<span class="product-label-link" type="condition" conceptid="432881" conceptname="Pancytopenia">pancytopenia</span>) or <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span> may be manifested in hours to days. Less frequent events are <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, <span class="product-label-link" type="condition" conceptid="195314" conceptname="Nephrotic syndrome">nephrotic syndrome</span>, <span class="product-label-link" type="condition" conceptid="4270887" conceptname="Erythroderma">exfoliative dermatitis</span>, neuropathies, and CNS stimulation or <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>. Although not well studied, methimazole-induced <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span> is generally associated with doses of 40 mg or more in patients older than 40 years of age.</p>
<p>No information is available on the median lethal dose of the drug or the concentration of methimazole in biologic fluids associated with toxicity and/or <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_8ceea390-abe6-4aa3-a3fe-0b8787a2472a"></a><a name="section-8.2"></a><p></p>
<h2>Treatment</h2>
<p class="First">To obtain up-to-date information about the treatment of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, a good resource is your certified Regional Poison Control Center. Telephone numbers of certified poison control centers are listed in the â€œPhysiciansâ€™ Desk Reference (PDR)â€?. In managing overdosage, consider the possibility of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">multiple drug overdoses</span>, interaction among drugs, and unusual drug kinetics in your patient.</p>
<p>Protect the patientâ€™s airway and support ventilation and perfusion. Meticulously monitor and maintain, within acceptable limits, the patientâ€™s vital signs, blood gases, serum electrolytes, etc. The patientâ€™s bone marrow function should be monitored. Absorption of drugs from the gastrointestinal tract may be decreased by giving activated charcoal, which, in many cases, is more effective than <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span> or lavage; consider charcoal instead of or in addition to gastric emptying. Repeated doses of charcoal over time may hasten elimination of some drugs that have been absorbed. Safeguard the patientâ€™s airway when employing gastric emptying or charcoal.</p>
<p>Forced <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">diuresis</span>, peritoneal dialysis, hemodialysis, or charcoal hemoperfusion have not been established as beneficial for an <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> of methimazole.</p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_6eb1d33f-d38d-497f-bc40-dea6efaa1536"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Methimazole is administered orally. It is usually given in 3 equal doses at approximately 8-hour intervals.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_2fd7fbe9-b533-43ab-b521-f26756e751de"></a><a name="section-9.1"></a><p></p>
<h2>Adults</h2>
<p class="First">The initial daily dosage is 15 mg for mild <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, 30 to 40 mg for moderately severe <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, and 60 mg for severe <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, divided into 3 doses at 8-hour intervals. The maintenance dosage is 5 to 15 mg daily.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_99945d98-6f56-492b-aa12-ac7bf602447a"></a><a name="section-9.2"></a><p></p>
<h2>Pediatric</h2>
<p class="First">Initially, the daily dosage is 0.4 mg/kg of body weight divided into 3 doses and given at 8-hour intervals. The maintenance dosage is approximately 1/2 of the initial dose.</p>
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-10"></a><p></p>
<h1>Methimazole 10mg Tablet</h1>
<div class="Figure"><img alt="Image File" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9e6b80b8-6780-da50-f18f-30e6fe7b01b9&amp;name=label1datamaxfda690.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>METHIMAZOLEÂ 		
					</strong><br><span class="contentTableReg">methimazole tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:63629-4331(NDC:49884-641)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>METHIMAZOLE</strong> (METHIMAZOLE) </td>
<td class="formItem">METHIMAZOLE</td>
<td class="formItem">10Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>LACTOSE MONOHYDRATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STARCH, CORN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>TALC</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE (off-white) </td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">8mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">EM;10</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:63629-4331-1</td>
<td class="formItem">30  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA040350</td>
<td class="formItem">07/07/2010</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Bryant Ranch Prepack
							(171714327)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant -Â </span>Bryant Ranch Prepack (171714327)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Bryant Ranch Prepack</td>
<td class="formItem"></td>
<td class="formItem">171714327</td>
<td class="formItem">REPACK(63629-4331), RELABEL(63629-4331)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 10/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>a8685718-f5c6-4d21-9fdc-becc809a22e9</div>
<div>Set id: 9e6b80b8-6780-da50-f18f-30e6fe7b01b9</div>
<div>Version: 2</div>
<div>Effective Time: 20121012</div>
</div>
</div>Â <div class="DistributorName">Bryant Ranch Prepack</div></p>
</body></html>
